Chemocentryx reported $-38738000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amgen AMGN:US $ 2333M 204M
AstraZeneca AZN:LN 1.4B 366M
Bayer BAYN:GR 1.64B 1.42B
Biogen BIIB:US $ 1030.1M 12.3M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bristol Myers Squibb BMY:US $ 2967M 411M
Chemocentryx CCXI:US $ -38738000 9.41M
GlaxoSmithKline GSK:LN 1.96B 281M
Glaxosmithkline GSK:US 1.96B 281M
Johnson & Johnson JNJ:US $ 6901M 94M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 3930M 332M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Novartis NOVN:VX 3.4B 415M
Omeros OMER:US $ -24016000 6.6M
Pfizer PFE:US $ 6662M 905M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Teva Pharmaceutical TEVA:IT 829M 35M
YTE INCY:US $ 155.31M 40.5M